Related Experiment Video
Updated: Nov 29, 2025
Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
Future directions for screening and treatment in congenital hearing loss
Ryan K Thorpe1, Richard J H Smith1
1Molecular Otolaryngology and Renal Research Laboratories, Carver College of Medicine, University of Iowa, 375 Newton Rd, Iowa City, IA 52242, USA.
Insights
Newborn hearing loss screening is crucial for child development. Combining genetic and cytomegalovirus testing with current methods improves early diagnosis and treatment of hearing deficits.
Area of Science:
- Pediatric audiology
- Neurodevelopmental disorders
- Genetics of hearing loss
Background:
- Hearing loss is the most common neurosensory deficit in children, impacting development.
- Early identification and intervention are key to mitigating adverse effects.
- Diagnosing hearing loss in newborns, particularly mild or progressive types, presents challenges.
Purpose of the Study:
- To review the current role of newborn hearing loss screening.
- To discuss the benefits of integrating genetic and cytomegalovirus testing.
- To explore future directions in neonatal hearing loss diagnosis and management.
Main Methods:
- Review of current literature on newborn hearing screening protocols.
- Analysis of the limitations of physiologic screening alone.
- Discussion of the advantages of multimodal diagnostic approaches.
Main Results:
- Physiologic newborn hearing screening enables earlier diagnosis.
- Concurrent genetic and cytomegalovirus testing addresses limitations of singular screening methods.
- A multidisciplinary approach is essential for effective management.
Conclusions:
- Integrating genetic and cytomegalovirus testing enhances newborn hearing loss detection.
- Multimodal screening strategies improve diagnostic accuracy and timeliness.
- Continued research is needed to refine diagnostic and therapeutic approaches for pediatric hearing loss.
Abstract:
Hearing loss is the most common neurosensory deficit. It results from a variety of heritable and acquired causes and is linked to multiple deleterious effects on a child's development that can be ameliorated by prompt identification and individualized therapies. Diagnosing hearing loss in newborns is challenging, especially in mild or progressive cases, and its management requires a multidisciplinary team of healthcare providers comprising audiologists, pediatricians, otolaryngologists, and genetic counselors. While physiologic newborn hearing screening has resulted in earlier diagnosis of hearing loss than ever before, a growing body of knowledge supports the concurrent implementation of genetic and cytomegalovirus testing to offset the limitations inherent to a singular screening modality. In this review, we discuss the contemporary role of screening for hearing loss in newborns as well as future directions in its diagnosis and treatment.
